IRIS PubliCatt

Mirabella, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.336
NA - Nord America 5.194
AS - Asia 1.745
AF - Africa 59
SA - Sud America 30
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 12.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.164
DE - Germania 1.906
SE - Svezia 1.169
CN - Cina 715
SG - Singapore 523
IT - Italia 506
UA - Ucraina 439
IE - Irlanda 325
FR - Francia 236
ID - Indonesia 206
GB - Regno Unito 159
FI - Finlandia 156
PL - Polonia 156
IN - India 132
RU - Federazione Russa 123
CI - Costa d'Avorio 48
TR - Turchia 43
BE - Belgio 40
VN - Vietnam 27
JP - Giappone 26
IR - Iran 25
CA - Canada 24
NL - Olanda 23
AU - Australia 13
ES - Italia 13
CZ - Repubblica Ceca 12
HK - Hong Kong 12
BR - Brasile 11
RO - Romania 11
CH - Svizzera 10
KR - Corea 10
A2 - ???statistics.table.value.countryCode.A2??? 8
CL - Cile 8
PT - Portogallo 6
AT - Austria 5
CO - Colombia 5
DK - Danimarca 5
HU - Ungheria 5
IL - Israele 4
LT - Lituania 4
MD - Moldavia 4
TH - Thailandia 4
BG - Bulgaria 3
CU - Cuba 3
EE - Estonia 3
GR - Grecia 3
HR - Croazia 3
MX - Messico 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
EC - Ecuador 2
EG - Egitto 2
EU - Europa 2
IQ - Iraq 2
KZ - Kazakistan 2
MA - Marocco 2
MK - Macedonia 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
AR - Argentina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
GE - Georgia 1
KE - Kenya 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 12.391
Salva come PNG Salva come JPEG
Città #
Chandler 1.168
Ashburn 432
Singapore 383
Dublin 320
Jacksonville 292
San Mateo 266
Jakarta 206
Wilmington 171
Ann Arbor 161
Nanjing 156
New York 155
Nürnberg 150
Warsaw 148
Boston 124
Houston 106
Redmond 104
Princeton 97
Woodbridge 97
Dearborn 95
Moscow 85
Beijing 80
Milan 73
Lawrence 72
Rome 71
Cattolica 66
Fairfield 64
Nanchang 63
Helsinki 60
Redwood City 60
Seattle 60
Munich 58
Marseille 54
Bremen 52
Abidjan 48
Chicago 48
Norwalk 45
Los Angeles 39
Brussels 36
Hebei 35
Izmir 35
Detroit 30
Mountain View 30
University Park 29
Kunming 26
Pune 26
Leawood 25
Boardman 24
Shenyang 23
Guangzhou 22
Tianjin 22
Shanghai 21
Jiaxing 20
Changsha 19
Hangzhou 19
Falls Church 16
Fremont 16
London 13
Washington 13
Zhengzhou 12
Cambridge 11
Florence 11
Falkenstein 10
Hanoi 9
Phoenix 9
Simi Valley 9
Toronto 9
Andover 8
Auburn Hills 8
Changchun 8
Edinburgh 8
Hefei 8
Hong Kong 8
Jinan 8
Lancaster 8
Paris 8
Philadelphia 8
Busto Arsizio 7
Fairport 7
Hounslow 7
Indiana 7
Lappeenranta 7
Seoul 7
São Paulo 7
Zurich 7
Ardabil 6
Atlanta 6
Bari 6
Berlin 6
Melbourne 6
Mola di Bari 6
Saint Louis 6
San Jose 6
Tokyo 6
Amsterdam 5
Augusta 5
Bogotá 5
Buffalo 5
Frankfurt am Main 5
Hyderabad 5
Landshut 5
Totale 6.534
Salva come PNG Salva come JPEG
Nome #
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 320
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 264
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 212
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 199
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 193
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 160
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 155
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 149
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 148
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 143
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 140
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 136
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 134
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 127
Muscle imaging findings in GNE myopathy 125
A Case of Hemiabdominal Myoclonus 125
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 120
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 118
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 115
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene 113
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 111
A human anti-Neuronal Autoantibody Against GABAB Receptor induces Experimental Autoimmune Agrypnia 110
Acyclovir-related kidney injury during alemtuzumab infusion 110
Muscle MRI in female carriers of dystrophinopathy 106
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle 103
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 102
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 102
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 101
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 98
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 97
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 95
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 93
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 92
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 91
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 91
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 91
Coeliac disease presenting with acute disseminated encephalomyelitis 90
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 90
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 88
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 86
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 85
TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis 84
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 83
Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy 81
Case of postpartum Parsonage-Turner syndrome 81
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 81
ANCA-related vasculitic neuropathy mimicking motor neuron disease. 79
A Case of Hemiabdominal Myoclonus 79
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 77
Bilateral thoracic long nerve involvement in motor multifocal neuropathy 77
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 77
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 77
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 76
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 76
Coeliac disease presenting with acute disseminated encephalomyelitis. 74
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 73
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 73
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 72
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 72
Fingolimod vs dimethyl fumarate in multiple sclerosis 72
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 71
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 71
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 70
Relapsing-remitting autoimmune agrypnia 70
Clinical characteristics, course and prognosis of spinal multiple sclerosis 70
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 69
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 69
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 69
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 68
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 67
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 67
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 66
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 66
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 66
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 66
Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration 65
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 64
Hereditary inclusion-body myopathies 63
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 62
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 61
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 61
Upper body involvement in GNE myopathy assessed by muscle imaging 61
Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy 60
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 60
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 60
Rasmussen encephalitis: an unusual cause for intractable seizures in elderly 60
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 60
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 60
Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration 60
Chapter 28- Hereditary Inclusion-Body Myopathies 59
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 59
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 58
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 58
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 57
A unique case of multiphasic ADEM or what else? 57
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 57
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 56
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta 54
Acyclovir-related kidney injury during alemtuzumab infusion 54
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 53
Totale 9.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020845 0 0 0 0 0 137 115 49 116 104 212 112
2020/20211.105 33 100 27 95 120 65 101 45 118 92 280 29
2021/20221.616 135 100 33 197 50 59 46 250 97 84 245 320
2022/20233.242 383 432 266 466 226 431 149 276 390 49 123 51
2023/20241.648 62 466 60 120 53 224 115 70 24 57 181 216
2024/2025966 79 99 308 144 205 131 0 0 0 0 0 0
Totale 12.615